US Archives - Page 108 of 192 - European Medical Journal

What Ambient AI Means for Epilepsy Clinics

Healthcare professionals and neurologists across the U.S. are closely watching the emergence of ambient AI tools in clinical practice, especially as these technologies enter specialized settings like epilepsy care.

GLP-1 Drugs May Curb Weight Gain After Quitting Smoking

GLP-1 receptor agonists (GLP-1 RAs), widely recognized for their role in metabolic disorders, may offer added support for smokers attempting to quit, according to findings presented at the 2025 American Psychiatric Association Annual Meeting.

1 in 10 Liver Transplant Patients Still Break Bones Despite Protocol

Liver transplant patients face a substantial risk of bone fractures despite following specialized care protocols, according to new findings.

Could Cannabis Be Harming the Skin?

As cannabis use continues to surge across the United States, a growing body of research is shedding light on its underrecognized dermatological consequences.

Cancer Risk Persists Despite HIV Treatment Success

A large international cohort study has found that people with HIV who achieve long-term virological suppression through antiretroviral therapy but experience suboptimal immune recovery are still at a significantly higher risk of developing cancer.

Understanding Pulmonary Hypertension: Interview with Todd Bull

I love physiology, and even during medical school I thought pulmonary and critical care would be a potential career path. My experience in…

Delirium Misdiagnosis Common in Spanish-Speaking ICU Patients: ATS 2025

Commonly used ICU delirium screening tools often misclassify Spanish-speaking patients according to new research presented at 2025 American Thoracic Society International (ATS) Conference in San Francisco.

Surge in Stage I Diagnoses Tied to Treatment Delays

A new national study published ahead of print in JCO Oncology Practice reveals a steady increase in time to treatment initiation (TTI) across all 30 of the most prevalent cancer types, with early-stage diagnoses now a major driver of these delays.

Can MS Damage Be Reversed? Exploring Novel Interventions

In a newly published systematic review of clinical trials, researchers evaluated the safety and efficacy of interventions aimed at promoting remyelination in multiple sclerosis (MS), a neurodegenerative disease characterized by inflammation, demyelination, and axonal damage in the central nervous system.

Why Preschool Asthma Treatment Guidelines Are Under Fire

Preschool asthma remains one of the most frequently encountered and challenging conditions in pediatric medicine and a new study explores the growing list of controversies surrounding its management.